Stock Track | Option Care Health Soars 5.08% on UBS Upgrade and Strong Q1 Earnings

Stock Track

May 01, 2025

Option Care Health Inc (NASDAQ: OPCH) saw its stock soar 5.08% during Wednesday's intraday trading session, following a notable upgrade from UBS and the release of impressive first-quarter 2025 financial results.

UBS raised its rating on Option Care Health from Neutral to Buy and increased its price target from $38 to $40. This upgrade comes on the heels of the company's strong Q1 2025 earnings report, which exceeded analyst expectations. Option Care Health reported revenue of $1.33 billion, up 16% year-over-year and 6% above analyst estimates. Earnings per share came in at $0.28, surpassing analyst projections by 3.2%.

The positive sentiment was further reinforced by Barrington Research, which maintained its Outperform rating on the stock. With an average analyst rating of Buy and a mean price target of $34.67, Option Care Health appears well-positioned for future growth. The company's robust performance in the face of rising healthcare demand and its ability to exceed market expectations have clearly resonated with investors, driving the significant stock price increase observed today.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1169380958"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169380958\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169380958?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 03:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169380958","market":"sg","top_or_hot":-1,"title":"Stock Track | Option Care Health Soars 5.08% on UBS Upgrade and Strong Q1 Earnings","media":"Stock Track","content":"<p>Option Care Health Inc (NASDAQ: OPCH) saw its stock soar 5.08% during Wednesday's intraday trading session, following a notable upgrade from UBS and the release of impressive first-quarter 2025 financial results.</p>\n\n<p>UBS raised its rating on Option Care Health from Neutral to Buy and increased its price target from $38 to $40. This upgrade comes on the heels of the company's strong Q1 2025 earnings report, which exceeded analyst expectations. Option Care Health reported revenue of $1.33 billion, up 16% year-over-year and 6% above analyst estimates. Earnings per share came in at $0.28, surpassing analyst projections by 3.2%.</p>\n\n<p>The positive sentiment was further reinforced by Barrington Research, which maintained its Outperform rating on the stock. With an average analyst rating of Buy and a mean price target of $34.67, Option Care Health appears well-positioned for future growth. The company's robust performance in the face of rising healthcare demand and its ability to exceed market expectations have clearly resonated with investors, driving the significant stock price increase observed today.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Option Care Health Soars 5.08% on UBS Upgrade and Strong Q1 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Option Care Health Soars 5.08% on UBS Upgrade and Strong Q1 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-01 03:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Option Care Health Inc (NASDAQ: OPCH) saw its stock soar 5.08% during Wednesday's intraday trading session, following a notable upgrade from UBS and the release of impressive first-quarter 2025 financial results.</p>\n\n<p>UBS raised its rating on Option Care Health from Neutral to Buy and increased its price target from $38 to $40. This upgrade comes on the heels of the company's strong Q1 2025 earnings report, which exceeded analyst expectations. Option Care Health reported revenue of $1.33 billion, up 16% year-over-year and 6% above analyst estimates. Earnings per share came in at $0.28, surpassing analyst projections by 3.2%.</p>\n\n<p>The positive sentiment was further reinforced by Barrington Research, which maintained its Outperform rating on the stock. With an average analyst rating of Buy and a mean price target of $34.67, Option Care Health appears well-positioned for future growth. The company's robust performance in the face of rising healthcare demand and its ability to exceed market expectations have clearly resonated with investors, driving the significant stock price increase observed today.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPCH","symbol_name":"Option Care Health Inc","start_time":0,"source_url":"","article_id":"1169380958","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169380958","pubTimestamp":1746042747,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Option Care Health Inc  saw its stock soar 5.08% during Wednesday's intraday trading session, following a notable upgrade from UBS and the release of impressive first-quarter 2025 financial results.UBS raised its rating on Option Care Health from Neutral to Buy and increased its price target from $38 to $40. This upgrade comes on the heels of the company's strong Q1 2025 earnings report, which exceeded analyst expectations. Option Care Health reported revenue of $1.33 billion, up 16% year-over-y","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPCH":"Option Care Health Inc"},"translate_title":"股票跟踪期权Care Health因瑞银升级和强劲的第一季度盈利而飙升5.08%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPCH":1},"content_text":"Option Care Health Inc (NASDAQ: OPCH) saw its stock soar 5.08% during Wednesday's intraday trading session, following a notable upgrade from UBS and the release of impressive first-quarter 2025 financial results.\nUBS raised its rating on Option Care Health from Neutral to Buy and increased its price target from $38 to $40. This upgrade comes on the heels of the company's strong Q1 2025 earnings report, which exceeded analyst expectations. Option Care Health reported revenue of $1.33 billion, up 16% year-over-year and 6% above analyst estimates. Earnings per share came in at $0.28, surpassing analyst projections by 3.2%.\nThe positive sentiment was further reinforced by Barrington Research, which maintained its Outperform rating on the stock. With an average analyst rating of Buy and a mean price target of $34.67, Option Care Health appears well-positioned for future growth. The company's robust performance in the face of rising healthcare demand and its ability to exceed market expectations have clearly resonated with investors, driving the significant stock price increase observed today.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}